{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Rosmarinus officinalis", "acetylcholinesterase", "carnosic acid", "molecular docking", "rosemary", "rosmarinic acid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35214846", "DateRevised": {"Year": "2022", "Month": "03", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "14"}], "Language": ["eng"], "ELocationID": ["514", "10.3390/plants11040514"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "14"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Phytochemical Screening of <i>Rosmarinus officinalis</i> L. as a Potential Anticholinesterase and Antioxidant-Medicinal Plant for Cognitive Decline Disorders.", "Abstract": {"AbstractText": ["The inhibition of acetylcholinesterase (AChE) by cholinergic agents has been promoted as a potent strategy for treating and managing cognitive decline disorders. A wide range of natural products has long been used as potential sources or formulations of cholinergic inhibitors. Therefore, this study aimed to evaluate different <i>Rosmarinus officinalis</i> L. (<i>R. officinalis</i>) extracts for their AChE inhibitory activity using galanthamine as a standard AChE inhibitor. In this study, the ethyl-acetate extract (at a concentration of 250 \u00b5g/mL) exhibited the greatest inhibitory effect against AChE with significant inhibition of 75%, comparable to the inhibitor galanthamine with an inhibition of 88%. Kinetic analysis revealed that the extracts could induce a mixed type of inhibition, as observed in the case of galanthamine, with the highest increased <i>Km</i> and decreased <i>Vmax</i> values in the ethyl acetate extract. The antioxidant potential of the three extracts tested was found to be in the order of ethyl-acetate > ethanol > aqueous, with IC<sub>50</sub> values of 272 \u00b5g/mL, 387 \u00b5g/mL, and 534 \u00b5g/mL, respectively. Ethyl-acetate was found to have the highest total phenolic content in all extracts. Further, in silico study showed structural binding characterization of rosmarinic acid and carnosic acid with human AChE enzyme. Rosmarinic acid showed strong binding and formed two hydrogen-bonding interactions with Ser-293 and Arg-296. In light of this, the ethyl-acetate extract of the plant may provide some novel potential pharmacological leads for treating and managing cognitive disorders such as Alzheimer's."]}, "AuthorList": [{"Identifier": ["0000-0003-0553-0046"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Center of Excellence in Bionanoscience Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Kamli", "ForeName": "Majid Rasool", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Jeddah Regional Lab, The Saudi Ministry of Health, Jeddah 21482, Saudi Arabia."}], "LastName": "Sharaf", "ForeName": "Abeer Abdullah M", "Initials": "AAM"}, {"Identifier": ["0000-0003-4785-9894"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Center of Excellence in Bionanoscience Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Sabir", "ForeName": "Jamal S M", "Initials": "JSM"}, {"Identifier": ["0000-0003-2752-0519"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Center of Excellence in Bionanoscience Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia."}], "LastName": "Rather", "ForeName": "Irfan A", "Initials": "IA"}], "GrantList": [{"GrantID": "D-264-130-1440", "Agency": "King Abdulaziz University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest. This research did not involve any animal and/or human participant. "}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "NIH  Alzheimer\u2019s Disease Fact Sheet.  [(accessed on 16 October 2021)];2021 July 8; Available online:  https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet."}, {"Citation": "Prince M., Bryce R., Albanese E., Wimo A., Ribeiro W., Ferri C.P. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement. 2013;9:63\u201375. doi: 10.1016/j.jalz.2012.11.007.", "ArticleIdList": ["10.1016/j.jalz.2012.11.007", "23305823"]}, {"Citation": "Matthews K.A., Xu W., Gaglioti A.H., Holt J.B., Croft J.B., Mack D., McGuire L.C. Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged \u226565 years. Alzheimers Dement. 2019;1:17\u201324. doi: 10.1016/j.jalz.2018.06.3063.", "ArticleIdList": ["10.1016/j.jalz.2018.06.3063", "PMC6333531", "30243772"]}, {"Citation": "Howes M.J.R., Perry E. The Role of Phytochemicals in the Treatment and Prevention of Dementia. Drug Aging. 2011;28:439\u2013468. doi: 10.2165/11591310-000000000-00000.", "ArticleIdList": ["10.2165/11591310-000000000-00000", "21639405"]}, {"Citation": "Yiannopoulou K.G., Papageorgiou S.G. Current and Future Treatments in Alzheimer Disease: An Update. J. Cent. Nerv. Syst. Dis. 2020;29:12. doi: 10.1177/1179573520907397.", "ArticleIdList": ["10.1177/1179573520907397", "PMC7050025", "32165850"]}, {"Citation": "Geula C., Darvesh S. Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer\u2019s disease. Drugs Today. 2004;40:711\u2013721. doi: 10.1358/dot.2004.40.8.850473.", "ArticleIdList": ["10.1358/dot.2004.40.8.850473", "15510242"]}, {"Citation": "Perry E., Walker M., Grace J., Perry R. Acetylcholine in mind: A neurotransmitter correlate of consciousness? Trends Neurosci. 1999;22:273\u2013280. doi: 10.1016/S0166-2236(98)01361-7.", "ArticleIdList": ["10.1016/S0166-2236(98)01361-7", "10354606"]}, {"Citation": "Schneider L.S. A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer\u2019s disease. Dialogues Clin. Neurosci. 2000;2:111\u2013128.", "ArticleIdList": ["PMC3181592", "22033801"]}, {"Citation": "Giacobini E. Cholinesterase inhibitors stabilize Alzheimer\u2019s disease. Ann. N. Y. Acad. Sci. 2000;920:321\u2013327. doi: 10.1111/j.1749-6632.2000.tb06942.x.", "ArticleIdList": ["10.1111/j.1749-6632.2000.tb06942.x", "11193171"]}, {"Citation": "Mukherjee P.K., Kumar V., Houghton P.J. Screening of Indian medicinal plants for acetylcholinesterase inhibitory activity. Phytother. Res. 2007;21:1142\u20131145. doi: 10.1002/ptr.2224.", "ArticleIdList": ["10.1002/ptr.2224", "17639556"]}, {"Citation": "Rollinger J.M., Schuster D., Baier E., Ellmerer E.P., Langer T., Stuppner H. Taspine: Bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana. J. Nat. Prod. 2006;69:1341\u20131346. doi: 10.1021/np060268p.", "ArticleIdList": ["10.1021/np060268p", "PMC3526713", "16989531"]}, {"Citation": "Konstantina G.Y., Sokratis G.P. Current and future treatments for Alzheimer\u2019s disease. Ther. Adv. Neurol. Disord. 2013;61:19\u201333.", "ArticleIdList": ["PMC3526946", "23277790"]}, {"Citation": "Mehta M., Adem A., Sabbagh M. New Acetylcholinesterase Inhibitors for Alzheimer\u2019s Disease. Int. J. Alzheimers Dis. 2012;2012:1\u20138. doi: 10.1155/2012/728983.", "ArticleIdList": ["10.1155/2012/728983", "PMC3246720", "22216416"]}, {"Citation": "Akhondzadeh S., Abbasi S.H. Herbal medicine in the treatment of Alzheimer\u2019s disease. Am. J. Alzheimers Dis. Other Dement. 2006;21:113\u2013118. doi: 10.1177/153331750602100211.", "ArticleIdList": ["10.1177/153331750602100211", "16634467"]}, {"Citation": "Mayeux R., Sano M. Treatment of Alzheimer\u2019s disease. N. Engl. J. Med. 1999;341:1670\u20131679. doi: 10.1056/NEJM199911253412207.", "ArticleIdList": ["10.1056/NEJM199911253412207", "10572156"]}, {"Citation": "Singh M., Kaur M., Kukreja H., Chugh R., Silakari O., Singh D. Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection. Eur. J. Med. Chem. 2013;70:165\u2013188. doi: 10.1016/j.ejmech.2013.09.050.", "ArticleIdList": ["10.1016/j.ejmech.2013.09.050", "24148993"]}, {"Citation": "Tian J., Shi J., Zhang X., Wang Y. Herbal therapy: A new pathway for the treatment of Alzheimer\u2019s disease. Alzheimers Res. Ther. 2010;2:30. doi: 10.1186/alzrt54.", "ArticleIdList": ["10.1186/alzrt54", "PMC2983439", "21067555"]}, {"Citation": "Li-Min F., Ju-Tzu L. A Systematic Review of Single Chinese Herbs for Alzheimer\u2019s Disease Treatment. Evid. Based Complement. Altern. Med. 2011;2011:640284. doi: 10.1093/ecam/nep136.", "ArticleIdList": ["10.1093/ecam/nep136", "PMC3136754", "19737808"]}, {"Citation": "Gonz\u00e1lez-Minero F.J., Bravo-D\u00edaz L., Ayala-G\u00f3mez A. Rosmarinus officinalis L. (Rosemary): An Ancient Plant with Uses in Personal Healthcare and Cosmetics. Cosmetics. 2020;7:77. doi: 10.3390/cosmetics7040077.", "ArticleIdList": ["10.3390/cosmetics7040077"]}, {"Citation": "Ribeiro-Santos R., Carvalho-Costa D., Cavaleiro C., Costa H.S., Albuquerque T.G., Castilho M.C., Ramos F., Melo N.R., Sanches-Silva A. A novel insight on an ancient aromatic plant: The rosemary (Rosmarinus officinalis L.) Trends Food Sci. Technol. 2015;45:355\u2013368. doi: 10.1016/j.tifs.2015.07.015.", "ArticleIdList": ["10.1016/j.tifs.2015.07.015"]}, {"Citation": "Amaral G.P., Mizdal C.R., Stefanello S.T., Mendez A.S.L., Puntel R.L., de Campos M.M.A., Soares F.A.A., Fachinetto R. Antibacterial and antioxidant effects of Rosmarinus officinalis L. extract and its fractions. J. Tradit. Complement. Med. 2018;9:383\u2013392. doi: 10.1016/j.jtcme.2017.10.006.", "ArticleIdList": ["10.1016/j.jtcme.2017.10.006", "PMC6702153", "31453135"]}, {"Citation": "Ra\u0161kovi\u0107 A., Milanovi\u0107 I., Pavlovi\u0107 N., \u0106ebovi\u0107 T., Vukmirovi\u0107 S., Mikov M. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Complement. Altern. Med. 2014;14:225. doi: 10.1186/1472-6882-14-225.", "ArticleIdList": ["10.1186/1472-6882-14-225", "PMC4227022", "25002023"]}, {"Citation": "Wang W., Li N., Luo M., Zu Y., Efferth T. Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules. 2012;17:2704\u20132713. doi: 10.3390/molecules17032704.", "ArticleIdList": ["10.3390/molecules17032704", "PMC6268287", "22391603"]}, {"Citation": "Allegra A., Tonacci A., Pioggia G., Musolino C., Gangemi S. Anticancer Activity of Rosmarinus officinalis L.: Mechanisms of Action and Therapeutic Potentials. Nutrients. 2020;12:1739. doi: 10.3390/nu12061739.", "ArticleIdList": ["10.3390/nu12061739", "PMC7352773", "32532056"]}, {"Citation": "Bao T.Q., Li Y., Qu C., Zheng Z.G., Yang H., Li P. Antidiabetic Effects and Mechanisms of Rosemary (Rosmarinus officinalis L.) and its Phenolic Components. Am. J. Chin. Med. 2020;48:1353\u20131368. doi: 10.1142/S0192415X20500664.", "ArticleIdList": ["10.1142/S0192415X20500664", "33016104"]}, {"Citation": "Ghasemzadeh Rahbardar M., Amin B., Mehri S., Mirnajafi-Zadeh S.J., Hosseinzadeh H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L. and rosmarinic acid in a rat model of neuropathic pain. Biomed. Pharmacother. 2017;86:441\u2013449. doi: 10.1016/j.biopha.2016.12.049.", "ArticleIdList": ["10.1016/j.biopha.2016.12.049", "28012923"]}, {"Citation": "Guti\u00e9rrez R., Alvarado J.L., Presno M., P\u00e9rez-Veyna O., Serrano C.J., Yahuaca P. Oxidative stress modulation by Rosmarinus officinalis in CCl4-induced liver cirrhosis. Phytother. Res. 2010;4:595\u2013601. doi: 10.1002/ptr.2997.", "ArticleIdList": ["10.1002/ptr.2997", "19827016"]}, {"Citation": "Singhal A.K., Naithani V., Bangar O.P. Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int. J. Nutr. Pharmacol. Neurol. Dis. 2012;2:84\u201391. doi: 10.4103/2231-0738.95927.", "ArticleIdList": ["10.4103/2231-0738.95927"]}, {"Citation": "Habtemariam S. Natural products in Alzheimer\u2019s disease therapy: Would old therapeutic approaches fix the broken promise of modern medicines? Molecules. 2019;24:1519. doi: 10.3390/molecules24081519.", "ArticleIdList": ["10.3390/molecules24081519", "PMC6514598", "30999702"]}, {"Citation": "Ozarowski M., Mikolajczak P.L., Bogacz A., Gryszczynska A., Kujawska M., Jodynis-Liebert J., Piasecka A., Napieczynska H., Szulc M., Kujawski R., et al. Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia. 2013;91:261\u2013271. doi: 10.1016/j.fitote.2013.09.012.", "ArticleIdList": ["10.1016/j.fitote.2013.09.012", "24080468"]}, {"Citation": "Sharma K. Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review) Mol. Med. Rep. 2019;20:1479\u20131487. doi: 10.3892/mmr.2019.10374.", "ArticleIdList": ["10.3892/mmr.2019.10374", "PMC6625431", "31257471"]}, {"Citation": "Lane R.M., Kivipelto M., Greig N.H. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin. Neuropharmacol. 2004;27:141\u2013149. doi: 10.1097/00002826-200405000-00011.", "ArticleIdList": ["10.1097/00002826-200405000-00011", "15190239"]}, {"Citation": "Guzior N., Wieckowska A., Panek D., Malawska B. Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease. Curr. Med. Chem. 2015;22:373\u2013404. doi: 10.2174/0929867321666141106122628.", "ArticleIdList": ["10.2174/0929867321666141106122628", "PMC4435057", "25386820"]}, {"Citation": "Dos Santos T.C., Gomes T.M., Pinto B.A.S., Camara A.L., Paes A.M.A. Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer\u2019s Disease Therapy. Front Pharmacol. 2018;18:1192. doi: 10.3389/fphar.2018.01192.", "ArticleIdList": ["10.3389/fphar.2018.01192", "PMC6201143", "30405413"]}, {"Citation": "Tungmunnithum D., Thongboonyou A., Pholboon A., Yangsabai A. Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: An Overview. Medicines. 2018;5:93. doi: 10.3390/medicines5030093.", "ArticleIdList": ["10.3390/medicines5030093", "PMC6165118", "30149600"]}, {"Citation": "Tanase C., Co\u0219arc\u0103 S., Muntean D.L. A Critical Review of Phenolic Compounds Extracted from the Bark of Woody Vascular Plants and Their Potential Biological Activity. Molecules. 2019;24:1182. doi: 10.3390/molecules24061182.", "ArticleIdList": ["10.3390/molecules24061182", "PMC6470986", "30917556"]}, {"Citation": "Roseiro L.B., Rauter A.P., Serralheiro M.L.M. Polyphenols as acetylcholinesterase inhibitors: Structural specificity and impact on human disease. Nutr. Aging. 2012;1:99\u2013111. doi: 10.3233/NUA-2012-0006.", "ArticleIdList": ["10.3233/NUA-2012-0006"]}, {"Citation": "Houghton P.J., Ren Y., Howes M.J. Acetylcholinesterase inhibitors from plants and fungi. Nat. Prod. Rep. 2006;23:181\u2013199. doi: 10.1039/b508966m.", "ArticleIdList": ["10.1039/b508966m", "16572227"]}, {"Citation": "Orhan I.E., Orhan G., Gurkas E. An overview on natural cholinesterase inhibitors\u2014A multi-targeted drug class\u2014And their mass production. Mini Rev. Med. Chem. 2011;11:836\u2013842. doi: 10.2174/138955711796575434.", "ArticleIdList": ["10.2174/138955711796575434", "21762104"]}, {"Citation": "Rosenfeld C.A., Sultatos L.G. Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon. Toxicol. Sci. 2006;90:460\u2013469. doi: 10.1093/toxsci/kfj094.", "ArticleIdList": ["10.1093/toxsci/kfj094", "16403852"]}, {"Citation": "Rahman A.-U., Khalid A., Sultana N., Nabeel Ghayur M., Ahmed Mesaik M., Khan M.R., Gilani A.H., Choudhary M.I. New natural cholinesterase inhibiting and calcium channel blocking quinoline alkaloids. J. Enzyme Inhib. Med. Chem. 2006;21:703\u2013710. doi: 10.1080/14756360600889708.", "ArticleIdList": ["10.1080/14756360600889708", "17252943"]}, {"Citation": "Mena P., Cirlini M., Tassotti M., Herrlinger K.A., Dall\u2019Asta C., del Rio D. Phytochemical Profiling of Flavonoids, Phenolic Acids, Terpenoids, and Volatile Fraction of a Rosemary (Rosmarinus officinalis L.) Extract. Molecules. 2019;21:1576. doi: 10.3390/molecules21111576.", "ArticleIdList": ["10.3390/molecules21111576", "PMC6273513", "27869784"]}, {"Citation": "Szwajgier D. Anticholinesterase activity of phenolic acids and their derivatives. Z. Nat. C J. Biosci. 2013;68:125\u2013132.", "ArticleIdList": ["23819308"]}, {"Citation": "Loussouarn M., Krieger-Liszkay A., Svilar L., Bily A., Birti\u0107 S., Havaux M. Carnosic Acid and Carnosol, Two Major Antioxidants of Rosemary, Act through Different Mechanisms. Plant Physiol. 2017;175:1381\u20131394. doi: 10.1104/pp.17.01183.", "ArticleIdList": ["10.1104/pp.17.01183", "PMC5664485", "28916593"]}, {"Citation": "Borr\u00e1s-Linares I., P\u00e9rez-S\u00e1nchez A., Lozano-S\u00e1nchez J., Barraj\u00f3n-Catal\u00e1n E., Arr\u00e1ez-Rom\u00e1n D., Cifuentes A., Micol V., Carretero A.S. A bioguided identification of the active compounds that contribute to the antiproliferative/cytotoxic effects of rosemary extract on colon cancer cells. Food Chem. Toxicol. 2015;80:215\u2013222. doi: 10.1016/j.fct.2015.03.013.", "ArticleIdList": ["10.1016/j.fct.2015.03.013", "25801906"]}, {"Citation": "Munn\u00e9-Bosch S., Schwarz K., Alegre L. Response of Abietane Diterpenes to Stress in Rosmarinus officinalis L.: New Insights into the Function of Diterpenes in Plants. Free Radic. Res. 1999;3:107\u2013112. doi: 10.1080/10715769900301391.", "ArticleIdList": ["10.1080/10715769900301391", "10694048"]}, {"Citation": "Demirezer L.\u00d6., G\u00fcrb\u00fcz P., Kelicen U\u011fur E.P., Bodur E., \u00d6zener N., Uz A., G\u00fcvenalp Z. Molecular docking and ex vivo and in vitro anticholinesterase activity studies of Salvia sp. and highlighted rosmarinic acid. Turk. J. Med. Sci. 2015;45:1141\u20131148. doi: 10.3906/sag-1404-42.", "ArticleIdList": ["10.3906/sag-1404-42", "26738360"]}, {"Citation": "Merad M., Soufi W., Ghalem S., Boukli F., Baig M.H., Ahmad K., Kamal M.A. Molecular interaction of acetylcholinesterase with carnosic acid derivatives: A neuroinformatics study. CNS Neurol. Disord. Drug Targets. 2014;13:440\u2013446. doi: 10.2174/18715273113126660157.", "ArticleIdList": ["10.2174/18715273113126660157", "24059305"]}, {"Citation": "Mannelli L.d., Micheli L., Maresca M., Cravotto G., Bellumori M., Innocenti M., Mulinacci N., Ghelardini C. Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors. Sci. Rep. 2016;6:34832. doi: 10.1038/srep34832.", "ArticleIdList": ["10.1038/srep34832", "PMC5054390", "27713514"]}, {"Citation": "Braca A., De Tommasi N., Di Bari L., Pizza C., Politi M., Morelli I. Antioxidant Principles from Bauhinia t arapotensis. J. Nat. Prod. 2001;64:892\u2013895. doi: 10.1021/np0100845.", "ArticleIdList": ["10.1021/np0100845", "11473417"]}, {"Citation": "Albano S.M., Lima A.S., Miguel M.G., Pedro L.G., Barroso J.G., Figueiredo A.C. Antioxidant, anti-5-lipoxygenase and antiacetylcholinesterase activities of essential oils and decoction waters of some aromatic plants. Rec. Nat. Prod. 2012;6:35\u201348."}, {"Citation": "Palmer T. Enzymes Biochemistry, Biotechnology, Clinical Chemistry. East-West Press Pvt Ltd.; Delhi, India: 2004."}, {"Citation": "Sheikh I.A. Stereoselectivity and potential endocrine disrupting activity of Bis-(2-ethylhexyl)phthalate (DEHP) against human progesterone receptor: A computational perspective. J. Appl. Toxicol. 2016;36:741\u2013774. doi: 10.1002/jat.3302.", "ArticleIdList": ["10.1002/jat.3302", "26879776"]}, {"Citation": "Ganaie A.A., Siddiqui H.R., Sheikh I.A. A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro and in vivo model systems. Mol. Carcinog. 2020;59:886\u2013896. doi: 10.1002/mc.23200.", "ArticleIdList": ["10.1002/mc.23200", "PMC7334075", "32291806"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "9"}, {"Year": "2022", "Month": "2", "Day": "8"}, {"Year": "2022", "Month": "2", "Day": "9"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "1", "Minute": "4"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["35214846", "PMC8877369", "10.3390/plants11040514", "plants11040514"]}}], "PubmedBookArticle": []}